Skip to content
Screener

Bristol-Myers Squibb BMY Q1 2025 earnings

Reported April 24, 2025 · Before market open

Revenue$11.2BBeat by $505.9M
EPS$1.80Beat by $0.31
Revenue estimate$10.7B
EPS estimate$1.49

Next report

Oct 29, 2026 (In 3 weeks)
Revenue estimate$12.6B
EPS estimate$1.68

Financials

Q1 2025

Income statement

See full
Revenue$11.2B-5.6%
Gross profit$8.2B-8.6%
Net income$2.5B+121%
EPS (diluted)$1.20+120%

Balance sheet

See full
Cash & equivalents$10.9B+16.6%
Total debt$49.9B-10.7%
Total equity$17.4B+5.5%
Total assets$92.4B-6.7%

Cash flow

See full
Operating cash flow$2.0B-31.1%
CapEx$260.0M-8.5%
Free cash flow$1.7B-33.6%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$124.1B+13.2%
Enterprise value$163.11B+4.4%
P/E23.2×—
P/S2.6×+0.2×

Profitability

See full
Gross margin70.5%-5.2pp
Net margin11.2%+7.3pp
FCF margin27.5%0.0pp

Returns & leverage

See full
Return on equity31.6%+21.8pp
Debt / equity2.9×-0.5×
Current ratio1.3×+0.2×

Segments

By product

See full
Eliquis$3.6B-4.2%
Opdivo$2.3B+9.0%
Revlimid$936.0M-43.9%
Orencia$770.0M-3.5%
Pomalyst/Imnovid$658.0M-23.9%

By geography

See full
Other$218.0M+9.5%

FAQ

When did Bristol-Myers Squibb report Q1 2025 earnings?
Bristol-Myers Squibb (BMY) reported Q1 2025 earnings on April 24, 2025 before market open.
What were Bristol-Myers Squibb's Q1 2025 revenue and EPS?
Bristol-Myers Squibb reported revenue of $11.2B and eps of $1.80 for Q1 2025.
Did Bristol-Myers Squibb beat estimates in Q1 2025?
Revenue beat the consensus estimate of $10.7B by $505.9M. EPS beat the consensus estimate of $1.49 by $0.31.
How did Bristol-Myers Squibb's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 5.6% from $11.9B a year earlier.
Where can I find Bristol-Myers Squibb's Q1 2025 SEC filings?
You can read the 8-K earnings release (0000014272-25-000089) and the 10-Q periodic report (0000014272-25-000091) directly on SEC EDGAR. The filing index links above go to sec.gov.